About
Chemotherapy
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
1,543
By Phase
PHASE2: 2PHASE1/PHASE2: 3PHASE3: 1NA: 1PHASE1: 1
By Status
TERMINATED: 4COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05678257Lead Sponsor
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
PHASE2Terminated
180 participants
Started: Apr 18, 2023 · Completed: Aug 29, 2024
NCT05714553Lead Sponsor
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
PHASE1/PHASE2Terminated
19 participants
Started: Mar 8, 2023 · Completed: May 30, 2025
NCT04163900Lead Sponsor
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
PHASE3Terminated
773 participants
Started: Dec 24, 2019 · Completed: Apr 5, 2022
NCT03829254Lead Sponsor
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
PHASE1/PHASE2Recruiting
135 participants
Started: Jun 17, 2019 · Completed: Aug 31, 2026
NCT03428958Lead Sponsor
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
PHASE1/PHASE2Completed
111 participants
Started: Oct 5, 2018 · Completed: Mar 21, 2024
Locations (1)
Headquarters
Newton, MA, United States
Map
Loading map...